Effects of SGLT2 inhibitors on triglyceride-derived indices among coronary heart disease patients with varying diabetes control status: a prospective cohort study
Event:
ESC Congress 2025
Topic:
Antidiabetic Pharmacotherapy
Session:
What's new for GLP-1 agonist and SGLT2 inhibitor cardiovascular pharmacotherapy?
Prevalence and Prognosis of Familial Hypercholesterolemia (FH) with Acute Myocardial Infarction (AMI) in China: Chinese Acute Myocardial Infarction (CAMI) Registry